COVID-19 in persons with chronic myeloid leukaemia
Research
[키워드] age
benefit
chronic myeloid leukaemia
CML
Complete
confidence
COVID-19
haematologic
Haematological cancer
health-care
hospitalised
Imatinib
increased risk
infected with SARS-CoV-2
interval
Isolation
molecular
Other
Person
Protective
questionnaire
receiving
reported
risk factor
SARS-CoV-2
SARS-CoV-2 epidemic
SARS-COV-2 infection
significantly
subject
subjects
Surveillance
TKI
tyrosine
[DOI] 10.1038/s41375-020-0853-6 [Article Type] Research
[DOI] 10.1038/s41375-020-0853-6 [Article Type] Research